Siemens Healthineers AG (SHL.DE)
43.35 EUR -0.12%
Siemens Healthineers AG fell 0.12% in the latest session, at 43.35 EUR. By market cap it is number 3 of the 6 health care stocks on the DAX 40 heatmap. Its trailing P/E of 22.0 is below the median of those peers (22.1). The price is 12.0% below its 52-week high.
Key numbers
- Price
- 43.35 EUR
- Day change
- -0.12% (-0.05)
- Market cap
- 48.5B EUR
- P/E (trailing)
- 22.0
- P/E (forward)
- 18.2
- Dividend yield
- 2.33%
- 50-day average
- 39.49
- 200-day average
- 37.75
- 52-week range
- 32.81 – 49.25
- Next earnings
- 5 Nov 2026
- Dividend per share (annual)
- 1.00 EUR
Data as of 3 Nov 2026, 17:38 CET. Market data may be delayed.
Siemens Healthineers AG over the past year
From daily closing prices. The highest close in the period was 49.25 EUR on 4 Nov 2025, the lowest 33.40 EUR on 15 May 2026.
| 1 month | 3 months | 6 months | Year to date | 1 year |
|---|---|---|---|---|
| +14.13% | +10.79% | +22.76% | -3.81% | -12.26% |
| Month | Close (EUR) | Change |
|---|---|---|
| November 2026 | 43.21 | +0.75% |
| October 2026 | 42.89 | +12.96% |
| September 2026 | 37.97 | -2.96% |
| August 2026 | 39.13 | +6.16% |
| July 2026 | 36.86 | +7.78% |
| June 2026 | 34.20 | -2.06% |
| May 2026 | 34.92 | +0.11% |
| April 2026 | 34.88 | -3.91% |
| March 2026 | 36.30 | -13.86% |
| February 2026 | 42.14 | -0.07% |
| January 2026 | 42.17 | -6.12% |
| December 2025 | 44.92 | +4.86% |
Health care peers
Siemens Healthineers AG is on the DAX 40 heatmap (Health care). How it compares with the other health care stocks there, by market cap:
| Company | Today | Market cap | P/E |
|---|---|---|---|
| Merck KGaA MRK.DE | -0.57% | 64.8B EUR | 27.4 |
| Bayer Aktiengesellschaft BAYN.DE | +3.64% | 50.9B EUR | — |
| Siemens Healthineers AG SHL.DE | -0.12% | 48.5B EUR | 22.0 |
| Fresenius SE & Co. KGaA FRE.DE | +0.47% | 27.5B EUR | 17.6 |
| Fresenius Medical Care AG FME.DE | -3.60% | 10.5B EUR | 11.8 |
| Qiagen N.V. QIA.DE | +0.04% | 9.3B EUR | 26.6 |
More on SHL
Open SHL.DE in zysk for the live chart, news, earnings and dividends, and ask the AI why it moved: it answers in a few lines with sources and a chart (how zysk's AI stock research works). zysk explains facts, news and risks; it is not investment advice.